English
  • Warning: Illegal string offset 'stockName' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'NSEcode' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).
  • Warning: array_column() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 33 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_multisort(): Argument #1 is expected to be an array or a sort flag in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 34 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_slice() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 36 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: Invalid argument supplied for foreach() in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 52 of modules/custom/five_paisa/src/MFHoldingService.php).
  1. Home
  2. Stocks
  3. Beta Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Beta Drugs

    Small Cap
    ₹1,210.00
    +15 (1.26%)
    01 July, 2024 06:51 BSE: 531481 NSE: BETAISIN: INE351Y01019

    Start SIP in Beta Drugs

    Start SIP

    Beta Drugs Performance

    Day Range

    • Low 1,195
    • High 1,220
    ₹ 1,210

    52 Week Range

    • Low 728
    • High 1,595
    ₹ 1,210
    • Open Price1,196
    • Previous Close1,195
    • Volume2100

    Beta Drugs Share Price

    • Over 1 Month -3.51%
    • Over 3 Month -1.93%
    • Over 6 Month -17.69%
    • Over 1 Year +53.16%

    Beta Drugs Key Statistics

    P/E Ratio
    PEG Ratio
    Market Cap Cr 1,163
    Price to Book Ratio 7.4
    EPS 22.8
    Dividend 0
    Relative Strength Index 46.22
    Money Flow Index 32.52
    MACD Signal -12.02
    Average True Range 45.33
    Beta Drugs Financials
    Indicator
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 199159
    Operating Expenses Annual Cr 164127
    Operating Profit Annual in Cr 3431
    Depreciation Cr 56
    Interest Annual Cr 11
    Tax Annual Cr 86
    Net Profit Annual Cr 2219
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 2110
    Cash from Investing Activity Annual Cr -11-6
    Cash from Financing Annual Activity Cr -1-2
    Net Cash Flow Annual Cr 2
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 11696
    Fixed Assets Annual Cr 3635
    Total Non Current Assets Annual Cr 5749
    Total Current Assets Annual Cr 11485
    Total Assets Annual Cr 170134
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 121100
    ROE Annual % 1920
    ROCE Annual % 2525
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1820
    Indicator
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 297228
    Operating Expenses Annual Cr 236174
    Operating Profit Annual in Cr 6053
    Depreciation Cr 1010
    Interest Annual Cr 32
    Tax Annual Cr 1210
    Net Profit Annual Cr 3631
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 3123
    Cash from Investing Activity Annual Cr -14-19
    Cash from Financing Annual Activity Cr -7-2
    Net Cash Flow Annual Cr 2
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 157123
    Fixed Assets Annual Cr 6563
    Total Non Current Assets Annual Cr 7671
    Total Current Assets Annual Cr 178128
    Total Assets Annual Cr 254198
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 163128
    ROE Annual % 2325
    ROCE Annual % 3032
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2124
    Invest in Beta Drugs

    Beta Drugs Technicals

    EMA & SMA

    Current Price
    ₹1,210.00
    +15 (1.26%)
    pointer
    • Bullish Moving Average
    • ___
    • 3
    • Bearish Moving Average
    • ___
    • 13
    • 20 Day
    • ₹1,221.98
    • 50 Day
    • ₹1,245.63
    • 100 Day
    • ₹1,254.40
    • 200 Day
    • ₹1,195.03
    • 20 Day
    • ₹1,219.54
    • 50 Day
    • ₹1,261.24
    • 100 Day
    • ₹1,273.79
    • 200 Day
    • ₹1,237.12

    Beta Drugs Resistance and Support

    PIVOT
    ₹1,208.34
    Resistance
    First Resistance 1,221.67
    Second Resistance 1,233.33
    Third Resistance 1,246.67
    RSI 46.22
    MFI 32.52
    MACD Single Line -12.02
    MACD -12.22
    Support
    First Support 1,196.67
    Second Support 1,183.33
    Third Supoort 1,171.67

    Beta Drugs Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 2,100 169,995 80.95
    Week 4,380 332,004 75.8
    1 Month 6,038 447,121 74.05
    6 Month 5,263 388,072 73.73

    Beta Drugs Result Highlights

    Beta Drugs Synopsis

    NSE-Medical-Diversified

    Beta Drugs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 157.87 Cr. and Equity Capital is Rs. 9.61 Cr. for the Year ended 31/03/2023. Beta Drugs Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230HP2005PLC028969 and registration number is 028969.
    Market Cap 1,163
    Sales 198
    Shares in Float 0.32
    No of funds 3
    Yield
    Book Value 10.03
    U/D Vol ratio 0.7
    LTDebt / Equity 3
    Alpha 0.07
    Beta 1.22

    Beta Drugs Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 66.73%66.73%66.73%66.73%
    Foreign Portfolio Investors 0.32%0.32%0.32%0.29%
    Individual Investors 22.35%22.33%22.37%22.24%
    Others 10.6%10.62%10.58%10.74%

    Beta Drugs Management

    Name Designation
    Mr. Rahul Batra Chairperson & Managing Director
    Mr. Varun Batra Joint Managing Director
    Mr. Balwant Singh Whole Time Director
    Mrs. Seema Chopra Whole Time Director
    Mr. Ashutosh Shukla Whole Time Director
    Mr. Rohit Parti Independent Director
    Mr. Manmohan Khanna Independent Director

    Beta Drugs Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Beta Drugs Corporate Action

    Date Purpose Remarks
    2024-05-14 Audited Results
    2023-11-07 Quarterly Results & Others To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of NSE and BSE.
    2023-05-08 Audited Results
    2022-10-27 Quarterly Results
    2022-04-27 Audited Results

    Beta Drugs MF Shareholding

    Name Amount(cr)

    Beta Drugs FAQs

    What is Share Price of Beta Drugs ?

    Beta Drugs share price is ₹1,210 As on 01 July, 2024 | 06:37

    What is the Market Cap of Beta Drugs ?

    The Market Cap of Beta Drugs is ₹1163.3 Cr As on 01 July, 2024 | 06:37

    What is the P/E ratio of Beta Drugs ?

    The P/E ratio of Beta Drugs is As on 01 July, 2024 | 06:37

    What is the PB ratio of Beta Drugs ?

    The PB ratio of Beta Drugs is 7.4 As on 01 July, 2024 | 06:37

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.